| | | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
| 2005N-0345
|
| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FDA Comment Number :
|
| EC9
|
|
|
|
|
| Submitter :
|
| Dr. TRACI CORDER
|
| Date & Time:
|
| 08/29/2005 12:08:21
|
|
|
|
|
| Organization :
|
| Dr. TRACI CORDER
|
|
|
|
|
| Category :
|
| Health Professional
|
|
|
|
|
| Issue Areas/Comments
|
|
|
|
|
|
| 2
|
|
|
|
|
|
|
|
| A. If FDA limited sale of an OTC product to a particular subpopulation, e.g., by making the product available to the subpopulation by prescription only, would FDA be able to enforce such a limitation as a matter of law?
|
|
|
|
|
|
|
|
|
|
|
| I feel it is unlawful to with hold certain medications to a subpopulations. They are either safe or they aren't safe. There is no biochemical difference in this subpopulation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|